Skip to main content
. 2015 Jun 1;2015(6):CD009566. doi: 10.1002/14651858.CD009566.pub2

Fujishima 2008.

Methods Parallel‐group RCT
Participants 32 participants recruited with seasonal and perennial allergic conjunctivitis
Interventions Two treatment arms: levocabastine; levocabastine and pemirolast potassium. Duration of treatment 1 week
Outcomes Participants used a diary to quantify ocular symptoms (itching, foreign body sensation, tearing, eye discharge, and hyperaemia) using visual analogue scale
Investigators used a 4‐point scale (0 = none, 3 = severe) for quantifying ocular signs: conjunctival hyperaemia, conjunctival oedema, eyelid oedema, conjunctival papilla formation, and superficial punctate keratopathy
Time points: at baseline and 1 week after treatment
Country Japan
Number randomised, gender (male:female) 32 participants randomised, 30 participants analysed. M:F 9:23
Age mean (SD), median, range Mean (range): levocabastine 50.9 years (12‐81); levocabastine and pemirolast potassium 40.5 years (7‐73)
Notes Not reported when study was conducted. Source of funding unclear. Declaration of interest by the authors was not stated
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Sealed‐envelope technique (p.233 ‐ test agents): "The patients were randomly allocated to one of two groups by a sealed‐enveloped technique…"
Allocation concealment (selection bias) Unclear risk The method used to conceal the allocation sequence was not described
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Data of all participants randomised was analysed and reported
Selective reporting (reporting bias) Low risk Evidence was available of proper outcome reporting
Other bias Low risk No apparent evidence of other risk of bias
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk The study did not describe details on masking of participants on the intervention allocations
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk The study did not describe details on masking of personnel/investigators on the intervention allocations